As of June 30, 2022 at 2 p.m., 498 cases have been confirmed: 336 in Ile-de-France, 44 in Auvergne-Rhône-Alpes, 36 in Occitanie, 27 in New Aquitaine, 16 in Provence-Alpes-Côte d’Azur, 19 in Hauts-de-France, 8 in Normandy, 4 in Brittany, 4 in Grand Est, 2 in Bourgogne-Franche-Comté, 1 in Centre-Val de Loire and 1 in Pays-de-la-Loire.
Among these cases, two new cases concern women, whose origin of the contamination is under investigation. This brings to 3 the number of women infected with the monkeypox virus since May 7, 2022, the date of the first case detected in France.
Confirmed adult cases are between 19 and 71 years old (median age: 35 years).
Symptom onset dates range between May 7, 2022 and June 27, 2022. These cases were diagnosed a median of 6 days (range 0-22 days) following symptom onset; therefore, data for the last week is not consolidated.
Among the cases investigated, 78% presented a genito-anal rash, 73% an eruption on another part of the body, 75% a fever and 72% lymphadenopathy. Among the cases investigated, 28 are immunocompromised; no cases died.
To date, as in other European countries, these cases have occurred mainly, but not exclusively, in men who have sex with men (MSM), with no direct link to people returning from endemic areas. The majority of cases report multiple sexual partners.
Most of the cases investigated declare that they cannot identify the person who allegedly infected them; 94 are secondary cases, ie having been in contact with a case of monkeypox in the three weeks preceding the onset of symptoms.
Among the cases investigated, 125 traveled, stayed or worked abroad, mainly in Europe, before the onset of their symptoms, some of them in several different countries. The countries most frequently cited are Spain (54 cases), Belgium (15), Germany (12), Portugal (8), the United Kingdom (7), Switzerland (5) and Morocco (5). These trips do not systematically constitute the origin of the contamination, and the list of countries cited may change as the data is consolidated.
